Skip to content
Open access · CC-BY via OpenAlex

Therapeutic potential of taurine in a pigmented rat model of age-related macular degeneration

Mohammed Attia, Tonja Pavlovič, Ashley Muliawan, Farjana Tuya, Maria Mihalatos, Marcin Iwanicki, Jennifer J. Kang‐Mieler

Frontiers in Ophthalmology · 2025 · ▲ 1 citations

Abstract

Purpose To investigate the potential protective effects of taurine supplementation against retinal degeneration in an animal model of mild dry age-related macular degeneration (AMD). Methods To test the effects of a taurine supplement in mild dry AMD, sodium iodate (NaIO 3 )-induced retinal degeneration model was used. Two administration methods, intraperitoneal (IP) and intravenous (IV), were used to deliver NaIO 3 in pigmented Long Evans rats to generate mild and severe dry AMD, respectively. Structural abnormalities were evaluated in vivo using near-infrared (IR) reflectance fundus imaging and optical coherence tomography (OCT). Using the slow progressive mild AMD model, we investigated the neuroprotective effects of oral taurine supplementation (1.5% w/v in drinking water) against NaIO 3 -induced retinal degeneration over 20 weeks. In addition, a human Retinal Pigment Epithelium (RPE, hTERT-RPE1) cell culture model was used to directly assess taurine’s ability to protect against NaIO 3 -related oxidative stress. Results The high-dose IV model (80 mg/kg) exhibited extensive and severe retinal damage, with ONL thinning by 64.2% and total retinal thickness (TRT) by 47.6%, predominantly in the peripapillary region. In contrast, the lower-dose IP model (50 mg/kg) displayed milder, more gradual deterioration (outer nuclear layer (ONL) thinning by 19.4% and TRT by 11.5%). Oral taurine supplementation significantly preserved ONL and TRT in vivo and supported RPE-1 cell survival, proliferation, and motility, under NaIO 3 conditions. Conclusion Taurine supplementation provided significant structural protection against NaIO 3 -induced damage both in vivo and in cell culture, demonstrating its potential as a therapeutic candidate for mitigating mild dry AMD progression.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.3389/fopht.2025.1701761
Canonical
link ↗
Fetched
2026-11-15 MST

Cite this

APA
Attia, M., Pavlovič, T., Muliawan, A., Tuya, F., Mihalatos, M., Iwanicki, M., &amp; Kang‐Mieler, J.J. (2025). Therapeutic potential of taurine in a pigmented rat model of age-related macular degeneration. <em>Frontiers in Ophthalmology</em>. https://doi.org/10.3389/fopht.2025.1701761
Vancouver
Attia M, Pavlovič T, Muliawan A, Tuya F, Mihalatos M, Iwanicki M, et al. Therapeutic potential of taurine in a pigmented rat model of age-related macular degeneration. Frontiers in Ophthalmology. 2025. doi:10.3389/fopht.2025.1701761.
BibTeX
@article{mohammed2025Therap, title = {Therapeutic potential of taurine in a pigmented rat model of age-related macular degeneration}, author = {Mohammed Attia and Tonja Pavlovič and Ashley Muliawan and Farjana Tuya and Maria Mihalatos and Marcin Iwanicki and Jennifer J. Kang‐Mieler}, journal = {Frontiers in Ophthalmology}, year = {2025}, doi = {10.3389/fopht.2025.1701761}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings